首页 | 本学科首页   官方微博 | 高级检索  
检索        

司帕沙星与洛美沙星片剂临床疗效及安全性的比较
引用本文:殷凯生,李梅梅,许志超,蔡健康.司帕沙星与洛美沙星片剂临床疗效及安全性的比较[J].实用临床医药杂志,1999(1).
作者姓名:殷凯生  李梅梅  许志超  蔡健康
作者单位:南京医科大学第一附属医院!南京,210009(殷凯生,李梅梅),南京医科大学第二附属医院!南京,210009(许志超,蔡健康)
摘    要:目的:评价抗菌新药司帕沙星片剂的临床疗效及安全性。方法:以洛美沙星片剂为对照,在73例急性细菌性感染患者中进行随机对照性研究。结果:试验组的痊愈率(84.21%)、有效率(92.11%)均高于对照组的痊愈率(65.71%)和有效率(82.86%),但统计学差异无显著性(P>0.05)。试验组患者不良反应发生率(5.3%)显著低于对照组(14.3%),P<0.05。结论:在细菌感染性疾病的治疗中,司帕沙星片剂优于洛美沙星片剂。

关 键 词:司帕沙星  洛美沙星  疗效  安全性

A COMPARISON ON CLINICAL EFFICACY AND SAFETY OF SPARFLOXACIN AND LOMEFLOXACIN
Yin Kaisheng, Xu Zhicao, Li Meimei,et al..A COMPARISON ON CLINICAL EFFICACY AND SAFETY OF SPARFLOXACIN AND LOMEFLOXACIN[J].Journal of Clinical Medicine in Practice,1999(1).
Authors:Yin Kaisheng  Xu Zhicao  Li Meimei  
Institution:Yin Kaisheng; Xu Zhicao; Li Meimei; et al.
Abstract:Aim: to evaluate the clinical efficacy and safety of Sparfloxacin tablets, a random con-trast study compared with Lomefloxacin tablts in 73 patients with acute infections caused by bacteria wasperformed. Result: the recovered rate (84. 21 % ) and effective rate (92. 11 % ) in the test group werehigher than the recovered rate (65. 71 % ) and effective rate (82. 86% ) in the contrast group, thoughthere were no significant differance statistically (P >O. O5). The side - effetive rate was 5. 3% in thetest group, which was lower than that (14. 3% ) in control group (P < 0. 05 ). Conclusion:Sparfloxacin tablets are better than Lomefloxacin tablets in treating acute infectious-diseases caused by bac-teria.
Keywords:Sparfloxacin  Lomefloxacin  efficacy  safety
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号